Effects of cyclopiazonic acid and aflatoxin singly and in combination on selected clinical, pathological and immunological responses of guinea pigs.
Cyclopiazonic acid (CPA) and aflatoxin are known sometimes to coexist in nature but little is known of possible biological interaction in mammals that consume mixtures of these two mycotoxins. Guinea pigs were dosed orally with CPA (2.2 mg/kg) or aflatoxin (0.045 mg B1/kg) singly or in combination. Effects of toxin consumption were determined on clinical health, body weight gain, pathological change, and several immunologically related parameters including delayed cutaneous hypersensitivity, antibody response, complement hemolytic titer, intracutaneous mitogen (PHA) and in vitro lymphocyte blastogenesis. In contrast to an earlier study by others, significant synergy between these two toxins was demonstrated in reduced rate of body weight gain, lethality and histologic changes (vacuolization) in hepatocytes. Reductions in complement titer, intradermal PHA, delayed cutaneous hypersensitivity response and in vitro lymphocyte blastogenesis were related to aflatin activity. No effects on antibody formation to Brucella abortus were observed with either toxin or the combination of toxins. Cyclopiazonic acid appeared to restore the suppressive effects of aflatoxin in delayed cutaneous hypersensitivity response and in vitro lymphocyte blastogenesis.
Department of Veterinary Sciences, University of Wyoming, Laramie 82071.
A C
AC
Pier
E L
EL
Belden
J A
JA
Ellis
E W
EW
Nelson
L R
LR
Maki
D000284:Administration, Oral; D000348:Aflatoxins / Q000008:administration & dosage / Q000633:toxicity*; D000818:Animals; D000907:Antibodies, Bacterial / Q000096:biosynthesis; D003165:Complement System Proteins / Q000032:analysis; D005260:Female; D005704:Gallbladder / Q000187:drug effects; D006168:Guinea Pigs; D007111:Immunity, Cellular / Q000187:drug effects; D007211:Indoles / Q000008:administration & dosage / Q000633:toxicity*; D008099:Liver / Q000187:drug effects; D008213:Lymphocyte Activation / Q000187:drug effects; D008297:Male; D009183:Mycotoxins / Q000008:administration & dosage / Q000633:toxicity*; D015430:Weight Gain / Q000187:drug effects
D000348:Aflatoxins; D000907:Antibodies, Bacterial; D007211:Indoles; D009183:Mycotoxins; D003165:Complement System Proteins; C000543:cyclopiazonic acid